We are happy to announce that Ewa Sroka from the former Neoantigen Science Group at International Centre for Cancer Vaccine Science has been awarded a Ph.D. degree with distinction from the University of Gdańsk for the project entitled ‘The role of alternative sources of antigenic peptides for the major histocompatibility complex class I in the formation of immune responses and immune tolerance.’
During the course of her studies, Ewa developed a novel mice model to study MHC I ligands that originate from non-conventional genomic locations like introns and investigated their role in immune tolerance, and immuno-oncology fields. The work was supervised by prof. Robin Fahraeus, performed at one of the INSERM laboratories in France, and reviewed by prof. dr. hab. Jerzy Henryk Ciesiołka from the Institute of Bioorganic Chemistry PAN, prof. dr. hab. Arkadiusz Miążek from Hirszfeld Institute of Immunology and Experimental Therapy PAN, and dr. Loredana Saveanu HDR from Université Paris Diderot.